JP2005517649A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005517649A5 JP2005517649A5 JP2003550818A JP2003550818A JP2005517649A5 JP 2005517649 A5 JP2005517649 A5 JP 2005517649A5 JP 2003550818 A JP2003550818 A JP 2003550818A JP 2003550818 A JP2003550818 A JP 2003550818A JP 2005517649 A5 JP2005517649 A5 JP 2005517649A5
- Authority
- JP
- Japan
- Prior art keywords
- acne
- hypothalamus
- administration
- activity
- applying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 16
- 239000000203 mixture Substances 0.000 claims 12
- 230000003255 anti-acne Effects 0.000 claims 11
- 241000124008 Mammalia Species 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 7
- 210000003016 hypothalamus Anatomy 0.000 claims 7
- 206010062767 Hypophysitis Diseases 0.000 claims 6
- 210000003635 pituitary gland Anatomy 0.000 claims 6
- 208000002874 Acne Vulgaris Diseases 0.000 claims 5
- 206010000496 acne Diseases 0.000 claims 5
- 239000000058 anti acne agent Substances 0.000 claims 5
- 229940124340 antiacne agent Drugs 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 210000001369 pituitary-adrenal system Anatomy 0.000 claims 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- 239000004342 Benzoyl peroxide Substances 0.000 claims 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 210000004100 adrenal gland Anatomy 0.000 claims 2
- 235000019400 benzoyl peroxide Nutrition 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 230000035882 stress Effects 0.000 claims 2
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 claims 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims 1
- 229960004308 acetylcysteine Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 230000001919 adrenal effect Effects 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
- 229960003328 benzoyl peroxide Drugs 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 230000037326 chronic stress Effects 0.000 claims 1
- 238000001723 curing Methods 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 229960004275 glycolic acid Drugs 0.000 claims 1
- 229960005280 isotretinoin Drugs 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- 230000004630 mental health Effects 0.000 claims 1
- 229960005323 phenoxyethanol Drugs 0.000 claims 1
- 229950001046 piroctone Drugs 0.000 claims 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims 1
- 230000001817 pituitary effect Effects 0.000 claims 1
- 229940107700 pyruvic acid Drugs 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 229960001755 resorcinol Drugs 0.000 claims 1
- 229930002330 retinoic acid Natural products 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 claims 1
- 230000001953 sensory effect Effects 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 229960005349 sulfur Drugs 0.000 claims 1
- 229960001727 tretinoin Drugs 0.000 claims 1
- 229960003500 triclosan Drugs 0.000 claims 1
- 229940045136 urea Drugs 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/012,627 US20020146469A1 (en) | 2000-12-20 | 2001-12-07 | Methods for reducing chronic stress in mammals |
| US10/017,180 US20020151527A1 (en) | 2000-12-20 | 2001-12-07 | Method for reducing acne or improving skin tone |
| PCT/US2002/038747 WO2003049769A2 (en) | 2001-12-07 | 2002-12-04 | Method for reducing acne or improving skin tone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005517649A JP2005517649A (ja) | 2005-06-16 |
| JP2005517649A5 true JP2005517649A5 (https=) | 2005-12-22 |
Family
ID=26683806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003550818A Pending JP2005517649A (ja) | 2001-12-07 | 2002-12-04 | アクネ減少法または皮膚の色合い改善法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1474170A1 (https=) |
| JP (1) | JP2005517649A (https=) |
| KR (1) | KR20040063166A (https=) |
| CN (1) | CN1615152A (https=) |
| AU (2) | AU2002359599A1 (https=) |
| BR (1) | BR0214993A (https=) |
| CA (1) | CA2469000A1 (https=) |
| MX (1) | MXPA04005499A (https=) |
| WO (1) | WO2003049769A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2327409A1 (en) * | 2001-07-13 | 2011-06-01 | Paratek Pharmaceuticals, Inc. | Tetracycline compound having target therapeutic activities |
| JP5388568B2 (ja) * | 2005-03-30 | 2014-01-15 | ルバンス セラピュティックス インク． | ざ瘡を治療するための組成物及び方法 |
| JP5109383B2 (ja) * | 2007-01-31 | 2012-12-26 | 大正製薬株式会社 | アダパレン含有外用剤組成物 |
| KR100861978B1 (ko) * | 2007-03-22 | 2008-10-07 | 한국콜마 주식회사 | 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법 |
| JP5522819B2 (ja) * | 2008-01-29 | 2014-06-18 | 株式会社マンダム | 抗菌性組成物及び皮膚外用剤 |
| WO2010009369A2 (en) * | 2008-07-17 | 2010-01-21 | Georgia Levis | Methods and materials for the treatment of acne |
| WO2012153884A1 (ko) * | 2011-05-12 | 2012-11-15 | (주)아모레퍼시픽 | 안정성이 향상된 여드름 개선용 조성물 |
| JP5840437B2 (ja) * | 2011-09-30 | 2016-01-06 | 日本メナード化粧品株式会社 | 抗炎症剤 |
| CN106420787B (zh) * | 2016-08-26 | 2020-05-26 | 陈启红 | 一种痤疮膏及其制备方法 |
| US12150949B2 (en) | 2018-07-30 | 2024-11-26 | Curology, Inc. | Compositions and methods of treating acne and photoaging |
-
2002
- 2002-12-04 BR BR0214993-1A patent/BR0214993A/pt not_active IP Right Cessation
- 2002-12-04 WO PCT/US2002/038747 patent/WO2003049769A2/en not_active Ceased
- 2002-12-04 JP JP2003550818A patent/JP2005517649A/ja active Pending
- 2002-12-04 KR KR10-2004-7008776A patent/KR20040063166A/ko not_active Ceased
- 2002-12-04 MX MXPA04005499A patent/MXPA04005499A/es unknown
- 2002-12-04 CN CNA028272994A patent/CN1615152A/zh active Pending
- 2002-12-04 EP EP02794147A patent/EP1474170A1/en not_active Withdrawn
- 2002-12-04 CA CA002469000A patent/CA2469000A1/en not_active Abandoned
- 2002-12-04 AU AU2002359599A patent/AU2002359599A1/en not_active Abandoned
-
2008
- 2008-07-25 AU AU2008203320A patent/AU2008203320A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005517649A5 (https=) | ||
| CN1220481C (zh) | 皮肤护理组合物 | |
| JP2012144544A (ja) | 甲状腺ホルモンまたは甲状腺ホルモン様アゴニスト化合物 | |
| CN1697645A (zh) | 改善皮肤的美观的化妆品组合物及其应用方法 | |
| JP5891651B2 (ja) | 角層細胞分化正常化用皮膚外用剤 | |
| Jafferany | Lithium and psoriasis: what primary care and family physicians should know | |
| Wallingford et al. | Increases in mature brain-derived neurotrophic factor protein in the frontal cortex and basal forebrain during chronic sleep restriction in rats: possible role in initiating allostatic adaptation | |
| Angeli-Besson et al. | CONFLUENT AND RETICULATED PAPILLOMATOSIS (GOUGEROT-CARTEAUC) TREATED WITH TETRACYCLINES. | |
| Hernandez et al. | Perspective: Transient postparturient hypocalcemia—A lactation-induced phenomenon of high-producing dairy cows | |
| BRPI0516992A (pt) | método de potencializar modulação imune e inflamatória para célula e terapia de droga | |
| Chosidow et al. | Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis | |
| Ambagaspitiya et al. | Impact of vitamin D on ultraviolet-induced photoaging and skin diseases | |
| Kürkçüoğlu et al. | Confluent and reticulated papillomatosis: response to topical calcipotriol | |
| Iraji et al. | Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma | |
| Shen et al. | Interleukine-1β and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization | |
| ITBS20120093A1 (it) | Composizione cosmetica e/o farmaceutica per il trattamento dell'infiammazione della cute e delle sindromi correlate | |
| Gollnick | Current perspectives on the treatment of acne vulgaris and implications for future directions. | |
| Zhou et al. | Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia, a case–control study | |
| CN119139160A (zh) | 一种温和抗老组合物及其制备方法、化妆品和应用 | |
| KR102112728B1 (ko) | 사카라이드의 미용 및 약제학적 용도 | |
| Kostarelos et al. | Double‐blind clinical study reveals synergistic action between alpha‐hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis | |
| Lee et al. | Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea | |
| Treat et al. | Nonpigmenting confluent and reticulated papillomatosis. | |
| DeWitt et al. | Should pressors be used to augment cerebral blood flow after traumatic brain injury? | |
| Bajaj | Transition from fetus to neonate |